Skip to main content

Peer Review reports

From: Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression

Original Submission
7 Sep 2022 Submitted Original manuscript
2 Oct 2022 Reviewed Reviewer Report
11 Oct 2022 Reviewed Reviewer Report
22 Oct 2022 Author responded Author comments - Chen Wang
Resubmission - Version 2
22 Oct 2022 Submitted Manuscript version 2
3 Nov 2022 Author responded Author comments - Chen Wang
Resubmission - Version 3
3 Nov 2022 Submitted Manuscript version 3
9 Nov 2022 Reviewed Reviewer Report
16 Nov 2022 Reviewed Reviewer Report
17 Nov 2022 Author responded Author comments - Chen Wang
Resubmission - Version 4
17 Nov 2022 Submitted Manuscript version 4
2 Dec 2022 Author responded Author comments - Chen Wang
Resubmission - Version 5
2 Dec 2022 Submitted Manuscript version 5
6 Dec 2022 Reviewed Reviewer Report
12 Dec 2022 Reviewed Reviewer Report
13 Dec 2022 Author responded Author comments - Chen Wang
Resubmission - Version 6
13 Dec 2022 Submitted Manuscript version 6
15 Dec 2022 Reviewed Reviewer Report
22 Jan 2023 Reviewed Reviewer Report
1 Feb 2023 Author responded Author comments - Chen Wang
Resubmission - Version 7
1 Feb 2023 Submitted Manuscript version 7
2 Feb 2023 Author responded Author comments - Chen Wang
Resubmission - Version 8
2 Feb 2023 Submitted Manuscript version 8
6 Feb 2023 Reviewed Reviewer Report
10 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
11 Feb 2023 Editorially accepted
20 Feb 2023 Article published 10.1186/s12920-023-01456-4

You can find further information about peer review here.

Back to article page